sarcosine has been researched along with Multiple System Atrophy Syndrome in 3 studies
cocobetaine: N-alkyl-betaine; cause of shampoo dermatitis
| Excerpt | Relevance | Reference |
|---|---|---|
| "Oligodendroglial cytoplasmic inclusions composed of alpha-synuclein filamentous aggregates are the pathological hallmark of multiple system atrophy (MSA)." | 7.72 | Annular alpha-synuclein species from purified multiple system atrophy inclusions. ( Gai, WP; Lowe, R; Pountney, DL; Quilty, M; Vickers, JC; Voelcker, NH, 2004) |
| "Neuronal and glial cytoplasmic inclusions (NCIs and GCIs), which contain alpha-synuclein as a major component, are characteristic cytopathological features of multiple system atrophy (MSA)." | 7.71 | Co-localization of alpha-synuclein and phosphorylated tau in neuronal and glial cytoplasmic inclusions in a patient with multiple system atrophy of long duration. ( Hasegawa, M; Hayashi, S; Ishikawa, A; Iwatsubo, T; Piao, YS; Takahashi, H; Wakabayashi, K; Yamada, M; Yoshimoto, M, 2001) |
| "Oligodendroglial cytoplasmic inclusions composed of alpha-synuclein filamentous aggregates are the pathological hallmark of multiple system atrophy (MSA)." | 3.72 | Annular alpha-synuclein species from purified multiple system atrophy inclusions. ( Gai, WP; Lowe, R; Pountney, DL; Quilty, M; Vickers, JC; Voelcker, NH, 2004) |
| "Neuronal and glial cytoplasmic inclusions (NCIs and GCIs), which contain alpha-synuclein as a major component, are characteristic cytopathological features of multiple system atrophy (MSA)." | 3.71 | Co-localization of alpha-synuclein and phosphorylated tau in neuronal and glial cytoplasmic inclusions in a patient with multiple system atrophy of long duration. ( Hasegawa, M; Hayashi, S; Ishikawa, A; Iwatsubo, T; Piao, YS; Takahashi, H; Wakabayashi, K; Yamada, M; Yoshimoto, M, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Woerman, AL | 1 |
| Kazmi, SA | 1 |
| Patel, S | 1 |
| Freyman, Y | 1 |
| Oehler, A | 1 |
| Aoyagi, A | 1 |
| Mordes, DA | 1 |
| Halliday, GM | 1 |
| Middleton, LT | 1 |
| Gentleman, SM | 1 |
| Olson, SH | 1 |
| Prusiner, SB | 1 |
| Pountney, DL | 1 |
| Lowe, R | 1 |
| Quilty, M | 1 |
| Vickers, JC | 1 |
| Voelcker, NH | 1 |
| Gai, WP | 1 |
| Piao, YS | 1 |
| Hayashi, S | 1 |
| Hasegawa, M | 1 |
| Wakabayashi, K | 1 |
| Yamada, M | 1 |
| Yoshimoto, M | 1 |
| Ishikawa, A | 1 |
| Iwatsubo, T | 1 |
| Takahashi, H | 1 |
3 other studies available for sarcosine and Multiple System Atrophy Syndrome
| Article | Year |
|---|---|
MSA prions exhibit remarkable stability and resistance to inactivation.
Topics: alpha-Synuclein; Animals; Biological Transport; Brain; Detergents; Disease Models, Animal; Fixatives | 2018 |
Annular alpha-synuclein species from purified multiple system atrophy inclusions.
Topics: alpha-Synuclein; Brain Chemistry; Cholic Acids; Detergents; Humans; Inclusion Bodies; Macromolecular | 2004 |
Co-localization of alpha-synuclein and phosphorylated tau in neuronal and glial cytoplasmic inclusions in a patient with multiple system atrophy of long duration.
Topics: Aged; alpha-Synuclein; Brain; Cytoplasm; Female; Gliosis; Humans; Immunoblotting; Immunohistochemist | 2001 |